Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today told DIrectorsTalk that the Company has agreed terms for the draw-down of an additional tranche
Convertible Promissory Note Extended to December 2017 Amphion announced that the holders of £5,707,738 Convertible Promissory Notes (CPNs) previously due on 31 December 2015 unanimously agreed to amend the terms
Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, has told DirectorsTalk that at a meeting on 26 February 2016, the holders of £5,707,738 Convertible Promissory
Further to the announcement of 8 October 2015, Kromek, a radiation detection technology company focusing on the medical, security and nuclear markets, has told DirectorsTalk that the Defense Advanced
Northland Capital partners view on Amphion Innovations (LON:AMP): Today’s announcement is a positive step forward for Amphion, as the group has effectively rolled over a large tranche of its debt,
Drawdown of an additional tranche of US $3m Amphion has agreed terms for the drawdown of an additional tranche of US $3m under its loan facility as announced on 5
Amphion Innovations plc (LSE: AMP), the developer of medical, life science, and technology businesses, today told DirectorsTalk that the Company has agreed terms for the draw-down of an additional tranche
It would appear that shares of Amphion Innovations are making a second serious attempt at changing trend to the upside, after first clearance of the 200 day moving average now
© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
